G
GSK
Corporate · Founded 1891 · London, United Kingdom
The funds GSK backs.
GSK is a limited partner in 14 funds. 2 of them place in the Power Law Investor Ranking; those lead, best-ranked first.
GSK’s biggest exits.
Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from GSK’s transaction record.
Where GSK’s portfolio is concentrated.
Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 57 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.
-
USA33
-
UK10
-
Switzerland5
-
Canada3
-
Denmark2
-
Germany2
-
Argentina1
-
China1
-
Health54
-
Energy2
-
Sports1
-
Series B+15
-
Series A8
-
Seed2
-
Late Growth34
-
Breakout Stage14
-
Early Growth6
-
Mature3
Inside GSK’s portfolio.
The 53 highest-funded portfolio companies, of 57 tracked.
Cu
23
Vi
Bo
Li
Ap
Sp
Se
Af
Ep
Ai
ID
RA
At
De
Nu
TE
An
Am
Sp
Re
CR
AsOu
Bi
Ch
Co
Ch
Wa
Si
Si
Si
Ne
Ce
35
Ge
Co
El
Gl
Se
Ge
Be
Pa
CaHa
Di
Ad
Hu
El
La
Ma
Do
PrWhere GSK’s portfolio founders come from.
65 founders across the 57 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.
-
United States41
-
United Kingdom8
-
Denmark3
-
Switzerland3
-
Germany2
-
China1
-
Cuba1
-
India1
-
Sweden1
-
University of Cambridge4
-
Yale University4
-
Cornell University3
-
Massachusetts Institute of Technology3
-
Columbia University2
-
Harvard University2
-
University College London2
-
University of Bristol2
-
University of California, Berkeley2
-
Wharton School of the University of Pennsylvania2
-
Juvenescence3
-
Dana-Farber Cancer Institute2
-
Scripps Translational Science Institute2
-
Third Rock Ventures2
-
Alexion Pharmaceuticals1
-
Andor Capital Management1
-
Anthem1
-
Apple Tree Partners1
-
Arsomedi1
-
Atlas Venture1
Similar investors.
Peers the API surfaces as most similar by portfolio shape, with Dealroom investor rank and portfolio scale.
